1. Home
  2. ARTNA vs CERS Comparison

ARTNA vs CERS Comparison

Compare ARTNA & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artesian Resources Corporation

ARTNA

Artesian Resources Corporation

HOLD

Current Price

$33.67

Market Cap

344.1M

Sector

Utilities

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.23

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTNA
CERS
Founded
1905
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
EDP Services
Sector
Utilities
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
344.1M
276.0M
IPO Year
1996
1997

Fundamental Metrics

Financial Performance
Metric
ARTNA
CERS
Price
$33.67
$2.23
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
32.7K
1.1M
Earning Date
03-24-2026
02-27-2026
Dividend Yield
3.72%
N/A
EPS Growth
12.02
N/A
EPS
2.18
N/A
Revenue
$111,776,000.00
$199,191,000.00
Revenue This Year
$7.82
$25.31
Revenue Next Year
$3.54
$9.50
P/E Ratio
$15.45
N/A
Revenue Growth
5.80
13.03
52 Week Low
$29.97
$1.12
52 Week High
$36.19
$2.96

Technical Indicators

Market Signals
Indicator
ARTNA
CERS
Relative Strength Index (RSI) 59.06 48.74
Support Level $32.56 $2.05
Resistance Level $33.49 $2.26
Average True Range (ATR) 0.70 0.14
MACD -0.01 -0.03
Stochastic Oscillator 98.84 39.39

Price Performance

Historical Comparison
ARTNA
CERS

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: